Pet Diabetes Care Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Pet Diabetes Care Market Size

Pet Diabetes Care Market is slated to witness remarkable growth from 2024 to 2032, fueled by the growing cases of pet diabetes caused by obesity across the globe. Diabetes can affect cats and dogs at any age, and it is highly prevalent in older pets. As per American Veterinary Medical Association, most cats affected by diabetes are older than 6 years. Pets affected by diabetes need lifelong treatment with fitness regimens, medications, special diets, insulin, and other care, which is bolstering the demand for pet care products and services.
 

Pet Diabetes Care Market Trends

As the trend of pet adoption becomes more widespread, novel innovations in pet diagnostics and medications are creating a strong support system for the pet care industry. As per European Pet Food Federation, around 90 million households in Europe, which makes up 46% of the region’s population, own companion animals. Across the European Union, approximately 25% of houses own a minimum of one cat or dog.
 

Pet Diabetes Care Market Analysis

Based on drug, insulin therapy segment is slated to witness substantial gains by 2032. Insulin therapy is regarded a cornerstone for efficiently managing animals with diabetes. It regulates the blood glucose levels and many variants of insulin have proven effective for managing diabetic pets. The improved dose accuracy of insulin pens for low insulin doses has bolstered the value for insulin therapy.
 

The pet diabetes care market from glucose monitoring device segment is expected to account for a major market share by 2032, driven by the accuracy, reliability, and efficiency of these devices. The increasing concerns about pet health among the pet parents, coupled with the growing disposable income and pet care spending throughout the globe will boost the demand for glucose monitoring devices.
 

The companion animal segment will generate notable revenues for the industry by 2032. Growing instances of nuclear families, and single living is fostering bouts of loneliness and depression among people across the world. As a result, many are turning to adopting pets such as dogs and cats as companion animals. The increasing expenditure on dog and cat healthcare is further spurring segment share.
 

The U.S. held a major share in the global pet diabetes care market in 2023 owing to its largest pet population, high expenditure on pet care, high disposable income, as well as the strong presence of renowned companies in the region. As per American Veterinary Medical Association, in the U.S. the mean annual expenses on veterinary visits for households with cats increased from USD 189 in 2020 to USD 321 in 2022. Furthermore, the presence of supportive animal welfare policies is also supplementing market outlook.
 

Pet Diabetes Care Market Share

Some of the key industry players include:

• Boehringer Ingelheim Vetmedica Inc.
• UltiMed Inc.
• Zoetis
• Merck & Co.
• Becton
• Dickinson and Company

They are working on developing strategies like product launches, mergers, and partnerships for profit and expansion.
 

Pet Diabetes Care Industry News

•  In September 2022, Zoetis Inc. acquired Jurox, an animal health enterprise specializing in the development, production, and distribution of veterinary medications for both livestock and companion animals. This acquisition marks a significant addition to Zoetis's assets, offering a diverse selection of crucial products poised for broader international reach.

What Information does this report contain?